Metallothionein's role in oxidative stress: A pathway to innovative treatments

PHARMACOLOGICAL RESEARCH · Published 2026-06-05 · DOI 10.1016/j.phrs.2026.108282

Free full text

Authors (3)

Ying Li, Ying Shao, Xiaoguang Shi

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Li, Y., Shao, Y., Shi, X. (2026). Metallothionein's role in oxidative stress: A pathway to innovative treatments. PHARMACOLOGICAL RESEARCH. https://doi.org/10.1016/j.phrs.2026.108282

Related articles

• Regulation of bone immunity by metal ions: a review of mechanisms and application progress · Frontiers in Immunology · 2026 · Cites or is cited by this article
• A multi-component intervention enhances intestinal urate excretion and improves metabolic and immune homeostasis in diet-induced hyperuricemia · PHARMACOLOGICAL RESEARCH · 2026 · Same journal
• Targeting pulmonary vascular–alveolar coupling in bronchopulmonary dysplasia: Therapeutic mechanisms and translational prospects of extracellular vesicle-based drug delivery · PHARMACOLOGICAL RESEARCH · 2026 · Same journal
• Targeting RNA quality-control defects in tauopathies: Pharmacodynamic biomarkers and therapeutic development · PHARMACOLOGICAL RESEARCH · 2026 · Same journal
• Neural and behavioral dynamics of acute fentanyl administration and implications for hazard assessment of novel synthetic opioids in larval zebrafish · PHARMACOLOGICAL RESEARCH · 2026 · Same journal
• Artesunate as an emerging anticancer modality: Insights and advances · PHARMACOLOGICAL RESEARCH · 2026 · Same journal
• Harnessing edible extracellular vesicles for inflammatory bowel disease: From natural immunomodulators to bioengineered oral nanotherapeutics · PHARMACOLOGICAL RESEARCH · 2026 · Same journal
• Targeting ATP-citrate lyase across cardiometabolic and oncologic disease · PHARMACOLOGICAL RESEARCH · 2026 · Same journal
• Innate immune surveillance and nucleic acid sensing: Gatekeepers of inflammatory cell death in respiratory infectious diseases · PHARMACOLOGICAL RESEARCH · 2026 · Same journal
• Sinomenine regulates the AKT/FOXO3/GLUL pathway to inhibit pulmonary fibroblast-to-myofibroblast transition via α7nAChR against rheumatoid arthritis associated interstitial lung disease · PHARMACOLOGICAL RESEARCH · 2026 · Same journal